JP2017520862A - 水溶性膜タンパク質ならびにその調製および使用方法 - Google Patents
水溶性膜タンパク質ならびにその調製および使用方法 Download PDFInfo
- Publication number
- JP2017520862A JP2017520862A JP2017502928A JP2017502928A JP2017520862A JP 2017520862 A JP2017520862 A JP 2017520862A JP 2017502928 A JP2017502928 A JP 2017502928A JP 2017502928 A JP2017502928 A JP 2017502928A JP 2017520862 A JP2017520862 A JP 2017520862A
- Authority
- JP
- Japan
- Prior art keywords
- seq
- protein
- transmembrane
- amino acid
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
- C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B15/00—ICT specially adapted for analysing two-dimensional or three-dimensional molecular structures, e.g. structural or functional relations or structure alignment
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B5/00—ICT specially adapted for modelling or simulations in systems biology, e.g. gene-regulatory networks, protein interaction networks or metabolic networks
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
- G16C20/00—Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
- G16C20/50—Molecular design, e.g. of drugs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Biophysics (AREA)
- Organic Chemistry (AREA)
- Theoretical Computer Science (AREA)
- Bioinformatics & Computational Biology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Evolutionary Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Medical Informatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Genetics & Genomics (AREA)
- Endocrinology (AREA)
- Pharmacology & Pharmacy (AREA)
- Physiology (AREA)
- Computing Systems (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461971388P | 2014-03-27 | 2014-03-27 | |
| US61/971,388 | 2014-03-27 | ||
| US201461993783P | 2014-05-15 | 2014-05-15 | |
| US61/993,783 | 2014-05-15 | ||
| US201562117550P | 2015-02-18 | 2015-02-18 | |
| US62/117,550 | 2015-02-18 | ||
| PCT/US2015/022780 WO2015148820A1 (en) | 2014-03-27 | 2015-03-26 | Water-soluble membrane proteins and methods for the preparation and use thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020070346A Division JP2020119589A (ja) | 2014-03-27 | 2020-04-09 | 水溶性膜タンパク質ならびにその調製および使用方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2017520862A true JP2017520862A (ja) | 2017-07-27 |
| JP2017520862A5 JP2017520862A5 (enExample) | 2018-05-17 |
Family
ID=54196406
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017502928A Pending JP2017520862A (ja) | 2014-03-27 | 2015-03-26 | 水溶性膜タンパク質ならびにその調製および使用方法 |
| JP2020070346A Pending JP2020119589A (ja) | 2014-03-27 | 2020-04-09 | 水溶性膜タンパク質ならびにその調製および使用方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020070346A Pending JP2020119589A (ja) | 2014-03-27 | 2020-04-09 | 水溶性膜タンパク質ならびにその調製および使用方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US20150370960A1 (enExample) |
| EP (2) | EP3805260A1 (enExample) |
| JP (2) | JP2017520862A (enExample) |
| AU (2) | AU2015237137A1 (enExample) |
| CA (1) | CA2978076A1 (enExample) |
| SG (1) | SG11201607980UA (enExample) |
| WO (1) | WO2015148820A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG10201701547VA (en) | 2011-02-23 | 2017-03-30 | Massachusetts Inst Technology | Water soluble membrane proteins and methods for the preparation and use thereof |
| HK1218858A1 (zh) | 2013-03-14 | 2017-03-17 | 麻省理工学院 | 用於长时间持续释放人类抗体的多层可注射自组装肽脚手架水凝胶 |
| WO2015149085A2 (en) * | 2014-03-27 | 2015-10-01 | Massachusetts Institute Of Technology | Warer-soluble trans-membrane proteins and methods for the preparation and use thereof |
| US10373702B2 (en) | 2014-03-27 | 2019-08-06 | Massachusetts Institute Of Technology | Water-soluble trans-membrane proteins and methods for the preparation and use thereof |
| US11293923B2 (en) | 2017-09-01 | 2022-04-05 | Massachusetts Institute Of Technology | S-layer protein 2D lattice coupled detergent-free GPCR bioelectronic interfaces, devices, and methods for the use thereof |
| CN108250290B (zh) * | 2018-02-23 | 2024-03-12 | 上海捌加壹医药科技有限公司 | Ccr4的n端重组蛋白及其用途 |
| US11401320B2 (en) | 2020-03-31 | 2022-08-02 | Massachusetts Institute Of Technology | QTY FC fusion receptor proteins |
| TW202216771A (zh) * | 2020-06-26 | 2022-05-01 | 德商拜耳廠股份有限公司 | 用於治療應用之ccr8抗體 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040215400A1 (en) * | 2003-01-21 | 2004-10-28 | The Trustees Of The University Of Pennsylvania | Computational design of a water-soluble analog of a protein, such as phospholamban and potassium channel KcsA |
| JP2010165216A (ja) * | 2009-01-16 | 2010-07-29 | National Institute Of Advanced Industrial Science & Technology | 立体構造データ帰属方法、立体構造データ帰属プログラム及び立体構造データ帰属装置 |
| JP2011133962A (ja) * | 2009-12-22 | 2011-07-07 | National Institute Of Advanced Industrial Science & Technology | 可溶性予測装置および可溶性予測方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007089899A2 (en) * | 2006-02-01 | 2007-08-09 | Oklahoma Medical Research Foundation | Water-soluble (g protein)-coupled receptor protein |
| SG10201701547VA (en) * | 2011-02-23 | 2017-03-30 | Massachusetts Inst Technology | Water soluble membrane proteins and methods for the preparation and use thereof |
| US20130273585A1 (en) * | 2012-04-11 | 2013-10-17 | Gangagen, Inc. | Soluble cytoplasmic expression of heterologous proteins in escherichia coli |
| WO2014176544A1 (en) * | 2013-04-25 | 2014-10-30 | The Trustees Of The University Of Pennsylvania | Water soluble g-protein coupled receptor |
-
2015
- 2015-03-26 JP JP2017502928A patent/JP2017520862A/ja active Pending
- 2015-03-26 WO PCT/US2015/022780 patent/WO2015148820A1/en not_active Ceased
- 2015-03-26 US US14/669,753 patent/US20150370960A1/en not_active Abandoned
- 2015-05-27 AU AU2015237137A patent/AU2015237137A1/en not_active Abandoned
- 2015-05-27 SG SG11201607980UA patent/SG11201607980UA/en unknown
- 2015-05-27 EP EP20184442.0A patent/EP3805260A1/en active Pending
- 2015-05-27 EP EP15729292.1A patent/EP3122767B1/en active Active
- 2015-05-27 CA CA2978076A patent/CA2978076A1/en active Pending
-
2017
- 2017-04-28 US US15/581,495 patent/US20170344699A1/en not_active Abandoned
-
2019
- 2019-09-16 AU AU2019232778A patent/AU2019232778B2/en active Active
-
2020
- 2020-04-09 JP JP2020070346A patent/JP2020119589A/ja active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040215400A1 (en) * | 2003-01-21 | 2004-10-28 | The Trustees Of The University Of Pennsylvania | Computational design of a water-soluble analog of a protein, such as phospholamban and potassium channel KcsA |
| JP2010165216A (ja) * | 2009-01-16 | 2010-07-29 | National Institute Of Advanced Industrial Science & Technology | 立体構造データ帰属方法、立体構造データ帰属プログラム及び立体構造データ帰属装置 |
| JP2011133962A (ja) * | 2009-12-22 | 2011-07-07 | National Institute Of Advanced Industrial Science & Technology | 可溶性予測装置および可溶性予測方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| AU2019232778A1 (en) | 2019-10-03 |
| US20170344699A1 (en) | 2017-11-30 |
| EP3122767A2 (en) | 2017-02-01 |
| AU2015237137A1 (en) | 2016-10-27 |
| EP3122767B1 (en) | 2020-07-08 |
| JP2020119589A (ja) | 2020-08-06 |
| SG11201607980UA (en) | 2016-10-28 |
| WO2015148820A1 (en) | 2015-10-01 |
| AU2019232778B2 (en) | 2021-09-09 |
| US20150370960A1 (en) | 2015-12-24 |
| CA2978076A1 (en) | 2015-10-01 |
| EP3805260A1 (en) | 2021-04-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20250285706A1 (en) | Water-soluble trans-membrane proteins and methods for the preparation and use thereof | |
| JP2017520862A (ja) | 水溶性膜タンパク質ならびにその調製および使用方法 | |
| Zhang et al. | Structural basis for chemokine recognition and receptor activation of chemokine receptor CCR5 | |
| Wu et al. | Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists | |
| Gao et al. | Interferon functional analog activates antiviral Jak/Stat signaling through integrin in an arthropod | |
| Carfí et al. | Structure of a soluble secreted chemokine inhibitor vCCI (p35) from cowpox virus | |
| Nagiri et al. | Cryo-EM structure of the β3-adrenergic receptor reveals the molecular basis of subtype selectivity | |
| Pease et al. | The attraction of chemokines as a target for specific anti‐inflammatory therapy | |
| Gong et al. | CD154-CD40 interactions are essential for thymus-dependent antibody production in zebrafish: insights into the origin of costimulatory pathway in helper T cell-regulated adaptive immunity in early vertebrates | |
| JP2025060920A (ja) | 水溶性膜貫通タンパク質ならびにその調製および使用方法 | |
| Singh et al. | Yeast surface display identifies a family of evasins from ticks with novel polyvalent CC chemokine-binding activities | |
| Lee et al. | A knottin scaffold directs the CXC-chemokine–binding specificity of tick evasins | |
| Huang et al. | De novo design of miniprotein antagonists of cytokine storm inducers | |
| Roy et al. | Exploiting agonist biased signaling of chemokines to target cancer | |
| Fano et al. | Modeling the structural basis of human CCR5 chemokine receptor function: from homology model building and molecular dynamics validation to agonist and antagonist docking | |
| WO2015149085A2 (en) | Warer-soluble trans-membrane proteins and methods for the preparation and use thereof | |
| Spiller et al. | Plant MDL proteins synergize with the cytokine MIF at CXCR2 and CXCR4 receptors in human cells | |
| Liu et al. | Structural basis of CXCR4 assembly and regulation | |
| HK40051625A (en) | Water-soluble trans-membrane proteins and methods for the preparation and use thereof | |
| WO2023186863A1 (en) | Computer-implemented design of peptide:receptor signaling complexes for enhanced chemotaxis | |
| Sang et al. | Structural mechanisms underlying the modulation of CXCR4 by diverse small-molecule antagonists | |
| JPH10505510A (ja) | ヒトmapキナーゼホモログ | |
| Brandhofer | Interactions between MIF-family proteins and the classical chemokine ligand/receptor network | |
| Eaton | Characterisation of novel evasins | |
| de Felice et al. | Drug Repurposing on G Protein-Coupled Receptors Using a Computational Profiling Approach. Front. Mol. Biosci. 8: 673053. doi: 10.3389/fmolb. 2021.673053 Drug Repurposing on G Protein-Coupled Receptors Using a Computational Profiling Approach Alessandra de Felice¹† |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20161116 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20180326 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20180326 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20190416 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20190709 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20190906 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20191210 |